Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Advanced Cancer 6Melanoma 3Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Malignancies Multiple 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Glioblastoma 1Endometrial Adenocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Advanced Gastric Cancer 1

Interventions

Cisplatin 5Platinum 4Cetuximab 41,2-diaminocyclohexaneplatinum II citrate 4Carboplatin 3Radiotherapy, Intensity-Modulated 2Nivolumab 2Immunoglobulin G 2Gemcitabine 2Gefitinib 2Fluorouracil 2Docetaxel 2Disulfides 2Biopsy 2Bevacizumab 2vandetanib 1temsirolimus 1linrodostat 1ficlatuzumab 1durvalumab 1dl1520 1dehydroftorafur 1cediranib 1atezolizumab 1adavosertib 1X-Rays 1Trioxsalen 1Specimen Handling 1Soybean Proteins 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoid Interstitial Pneumonia × linrodostat × Clear all
NCT03854032 2025-06-06

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

Thomas Jefferson University

Phase 2 Active not recruiting
45 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡